The Endocrinology and Developmental Biology of the Prostate*
Clicks: 6
ID: 298090
1987
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Steady Performance
1.5
/100
6 views
3 readers
AI Quality Assessment
Not analyzed
Readership in this journal
SteadyRanked #131 of 220 articles by views in endocrine reviews
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 220 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
MALE accessory sex glands such as the prostate, seminal vesicle, and bulbourethral gland have served in various capacities as models for investigating the action of androgens in regulating epithelial growth, RNA and protein synthesis, and secretory activity. The most extensively studied gland of this group is the prostate. This gland is found exclusively in mammals and produces many components of semen such as fructose, zinc ions, and various proteins important for the formation of the copulatory plug in rodents. The impetus for investigating regulation of prostatic growth and function stems in part from the many pathological complications which affect this gland. The prostate is the site of various types of inflammatory and infectious conditions (1) as well as benign and malignant proliferative changes in aging males. Despite extensive research, little of the pathogenesis or natural history of these diseases has been elucidated (2). Benign prostatic hypertrophy (BPH), a disease in which the prostate resumes growth late in life, is the most common nonmalignant proliferative abnormality found in any internal organ (2). The incidence of BPH rises from 23% in men at 40 yr of age to 88% by the ninth decade (3). Adenocarcinoma of the prostate is the third leading cause of cancer deaths among men. Approximately 69 cases/100,000 men are diagnosed each year in the United States. It remains an intriguing paradox that malignant prostatic tumors are among the most prevalent neoplasms in men, while the seminal vesicles and bubulbourethral gland remain nearly immune to neoplastic change (<1 case of carcinoma of the seminal vesicle per year) (4).
| Reference Key |
openalex_W1997348862
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Gerald R. Cunha, Annemarie A. Donjacour, Paul S. Cooke, HSARRON MEE, Robert M. Bigsby, STEPHEN J. HIGGINS, Yoshiki Sugimura |
| Journal | endocrine reviews |
| Year | 1987 |
| DOI |
10.1210/edrv-8-3-338
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.